KRAS and colorectal carcinoma: In addition, recent reports have confirmed that the expression levels of the KRAS-4A transcript are notably decreased in colorectal adenocarcinoma (CRC), highlighting that KRAS splicing is notably altered and therefore indicating that the balance among the expression levels of the KRAS splice variants may have a significant role in CRC tumorigenesis [41].